The American Journal of Chinese Medicine · 2020 · 23 citations · 23 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyCellular PharmacologyMolecular PharmacologyAngiogenesisCardiovascular DiseaseCardiovascular PharmacologyCoronary Artery DiseaseIschemic Heart DiseaseMedicinal PlantsAngiogenic Factor ExpressionEndothelial Tube FormationMechanisms Of Cardiac InjuryMyocardial Infarction PharmacotherapyMyocardial Ischemia MarkersOxidative Stress In Cardiovascular DiseaseOxidative Stress InjuryVascular Endothelial Growth Factor
The Chinese patent medicine She-Xiang-Xin-Tong-Ning (SXXTN) is a clinical medication for coronary heart disease (CHD) and angina pectoris. This study aimed to investigate pharmacological effects of SXXTN and elucidate the role in angiogenesis on human umbilical vein endothelial cells (HUVECs) and acute myocardial ischemia (AMI) rats. We prepared SXXTN to treat the cells to reveal their effects on oxidative stress-damaged cell viability, as well as cell proliferation, migration, and tube formation processes. SXXTN was also used to treat coronary artery ligation-induced acute myocardial ischemia rats to confirm whether it had positive effect on myocardial issues by hematoxylin and eosin (HE), 2,3,5-triphenyltetrazolium chloride (TTC) staining and immunohistochemical staining. We measured the levels of peroxidative damage-related enzymes in cytoplasm and serum by biochemical kits and detected vascular endothelial growth factor (VEGF), angiotensin II (Ang II), thromboxane B2 (TXB2), and 6-keto-prostaglandin F1 alpha (6-keto-PGF1[Formula: see text]) levels in cells and rats by enzyme-linked immunosorbent assay (ELISA) kits. The results showed that SXXTN protects HUVECs against oxidative stress damage and reversed the decrease of superoxide dismutase (SOD), glutathione (GSH) and increase of creatine kinase (CK), lactate dehydrogenase (LDH) caused by oxidative stress. SXXTN promoted angiogenesis through stimulating cell migration, tube formation, and activating VEGF/VEGFR2 and ERK1/2 pathways. Furthermore, SXXTN reduced infarct size and inhibited PGI2/TXA2 imbalance, preventing atherosclerosis plaque rupture leading to worsening coronary heart disease. Taken together, we report the first in vivo and in vitro evidence that SXXTN reduced oxidative stress-mediated damage and enhanced angiogenesis, which might be useful in treatment of myocardial infarction.
23
Theo Vos, Amanuel Alemu Abajobir, Kalkidan Hassen Abate et al. · The Lancet · 2017 · 13.5K citations · Full text
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain
Zheng Gang Zhang, Li Zhang, Quan Jiang et al. · Journal of Clinical Investigation · 2000 · 1.3K citations · Full text
Medicine, Neurology, Neuroscience +16
Jae Ju Jeong, Yu Mi Ha, Yong Chun Jin et al. · Food and Chemical Toxicology · 2009 · 95 citations